Ieq Capital, LLC Ocular Therapeutix, Inc Transaction History

Ieq Capital, LLC

$8.04 Billion
Q3 2024

A detailed history of Ieq Capital, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 17,629 shares of OCUL stock, worth $149,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,629

Previous 17,629 -0.0%

Holding current value

$149,846

Previous $120,000 27.5%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.2 - $8.69 $52,500 - $108,625	-12,500 Reduced 41.49%	17,629 $120,000
Q4 2023 Feb 07, 2024	SELL	$2.08 - $4.52 $113,152 - $245,887	-54,400 Reduced 64.36%	30,129 $134,000
Q1 2023 May 01, 2023	SELL	$2.79 - $6.27 $153,450 - $344,850	-55,000 Reduced 39.42%	84,529 $445,000
Q4 2022 Feb 03, 2023	SELL	$2.61 - $4.41 $376,894 - $636,821	-144,404 Reduced 50.86%	139,529 $392,000
Q2 2022 Jul 27, 2022	SELL	$3.01 - $5.22 $373,240 - $647,280	-124,000 Reduced 30.4%	283,933 $1.14 Million
Q4 2021 Jan 31, 2022	SELL	$6.16 - $12.07 $1.36 Million - $2.67 Million	-221,049 Reduced 35.14%	407,933 $2.84 Million
Q3 2021 Nov 09, 2021	BUY	$9.7 - $14.34 $475 - $702	49 Added 0.01%	628,982 $6.29 Million
Q4 2020 Feb 03, 2021	SELL	$7.91 - $22.95 $397,873 - $1.15 Million	-50,300 Reduced 7.41%	628,933 $13 Million
Q2 2020 Jul 31, 2020	BUY	$4.67 - $8.95 $1.98 Million - $3.79 Million	423,188 Added 165.28%	679,233 $5.66 Million
Q4 2019 Feb 04, 2020	BUY	$2.57 - $4.73 $658,035 - $1.21 Million	256,045 New	256,045 $1.01 Million

Others Institutions Holding OCUL

# of Institutions

171

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account